Advancements in Pharmacological Treatment of Pregnancy-Induced Hypertension

Abstract

Pregnancy-induced hypertension (PIH) is a common obstetric disease characterized by clinical symptoms such as proteinuria, hypertension, and edema. It may even lead to heart and kidney failure, posing a serious threat to the life safety of pregnant women and neonates. Therefore, it is imperative to enhance hemodynamic monitoring for pregnant women and provide personalized prevention and treatment strategies. Medication plays a crucial role in managing pregnancy-induced hypertension, with diuretics, antihypertensive agents, and antispasmodics being the primary pharmacological interventions to improve the condition. This research, validated through literature review, focuses on the progress in drug research related to pregnancy-induced hypertension, aiming to contribute new insights to the clinical diagnosis and treatment of PIH.